Does WHOOP’s biomarker integration move wearables closer to regulated healthcare?
WHOOP launches Advanced Labs in the UAE with Unilabs, integrating 65 biomarkers into its wearable platform. Explore what this shift means.
Why Illumina’s investment in MyOme could reset expectations for genome-based prevention
Illumina, Inc. and MyOme, Inc. have announced a new strategic collaboration, including an equity investment by Illumina to support MyOme’s upcoming Proactive Health (MPH) Trial. The large-scale clinical study, expected to begin in 2026, will evaluate the impact of artificial intelligence-integrated whole-genome sequencing on chronic disease prevention and cost savings across the U.S. healthcare system. […]